相似文献
1
Metformin-to use or not to use . . . is that the question?
Kidney Int. 2020 Nov;98(5):1105-1107. doi: 10.1016/j.kint.2020.07.021.
2
Metformin in chronic kidney disease: more harm than help?
Lancet Diabetes Endocrinol. 2015 Aug;3(8):579-81. doi: 10.1016/S2213-8587(15)00133-3. Epub 2015 Jun 17.
3
Mortality and metformin use in patients with advanced chronic kidney disease.
Lancet Diabetes Endocrinol. 2015 Sep;3(9):680-1. doi: 10.1016/S2213-8587(15)00285-5.
4
Metformin should not be contraindicated in patients with type 2 diabetes and mild to moderate renal impairment.
Evid Based Med. 2015 Jun;20(3):115. doi: 10.1136/ebmed-2015-110184. Epub 2015 Mar 31.
5
Restricting Metformin in CKD: Continued Caution Warranted.
Am J Kidney Dis. 2015 Dec;66(6):1101-2. doi: 10.1053/j.ajkd.2015.07.039.
6
Chronic kidney disease: Metformin increases risk of mortality in patients with advanced chronic kidney disease.
Nat Rev Nephrol. 2015 Aug;11(8):443. doi: 10.1038/nrneph.2015.110. Epub 2015 Jul 7.
7
Mortality and metformin use in patients with advanced chronic kidney disease--Authors' reply.
Lancet Diabetes Endocrinol. 2015 Sep;3(9):681. doi: 10.1016/S2213-8587(15)00287-9.
8
In Reply to 'Restricting Metformin in CKD: Continued Caution Warranted'.
Am J Kidney Dis. 2015 Dec;66(6):1102. doi: 10.1053/j.ajkd.2015.09.012.
9
Metformin Use in Type 2 Diabetes Mellitus With CKD: Is It Time to Liberalize Dosing Recommendations?
Am J Kidney Dis. 2015 Aug;66(2):193-5. doi: 10.1053/j.ajkd.2015.04.001. Epub 2015 May 8.
10
Therapy: Risk of metformin use in patients with T2DM and advanced CKD.
Nat Rev Endocrinol. 2015 Dec;11(12):697-9. doi: 10.1038/nrendo.2015.132. Epub 2015 Aug 18.
引用本文的文献
1
Modulation of Altered Immune Parameters IL-2 and TNF-α in Diabetic Animal Models: A Therapeutic Insinuation of Metformin Beyond Diabetes.
Cureus. 2023 Sep 14;15(9):e45216. doi: 10.7759/cureus.45216. eCollection 2023 Sep.
Zotero 插件